WallStSmart
HCAT

Health Catalyst Inc

NASDAQ: HCAT · HEALTHCARE · HEALTH INFORMATION SERVICES

$1.25
-1.57% today

Updated 2026-04-30

Market cap
$100.81M
P/E ratio
P/S ratio
0.32x
EPS (TTM)
$-2.55
Dividend yield
52W range
$1 – $5
Volume
0.8M

WallStSmart proprietary scores

37
out of 100
Grade: D
Sell
Investment rating
3.3
Growth
D
4.5
Quality
C
2.0
Profitability
F
6.7
Valuation
B
2/9
Piotroski F-Score
Weak
-1.1
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$1.96
+57.12%
12-Month target
Intrinsic (DCF)
$18.14
Margin of safety
+89.03%
0 Strong Buy3 Buy8 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $9.64M — positive
+ 89.03% below intrinsic value
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -1.07 — distress zone
- Thin margins at -57.20%
- Revenue declining -6.20% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$276.24M$295.94M$306.58M$311.14M$311.14M
Net income$-137.40M$-118.15M$-69.50M$-177.97M$-91.03M
EPS$-2.55
Free cash flow$-52.68M$-47.39M$-1.84M$-237000.00$9.64M
Profit margin-49.74%-39.92%-22.67%-57.20%-57.20%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
HCAT$100.81M373.32.06.74.5+89.03%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Health Catalyst Inc trades at $1.25. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -1.07, it sits in the distress. TTM revenue stands at $311.14M. with profit margins at -57.20%. Our DCF model estimates intrinsic value at $18.14.

Frequently asked questions

What is Health Catalyst Inc's stock price?
Health Catalyst Inc (HCAT) trades at $1.25.
Is Health Catalyst Inc overvalued?
Smart Value Score 37/100 (Grade D, Sell). DCF value $18.14.
What is the price target of Health Catalyst Inc (HCAT)?
The analyst target price is $1.96, representing +57.1% upside from the current price of $1.25.
What is the intrinsic value of Health Catalyst Inc (HCAT)?
Based on our DCF model, intrinsic value is $18.14, a +89.0% margin of safety versus $1.25.
What is Health Catalyst Inc's revenue?
TTM revenue is $311.14M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-1.07 — distress.

Company info

SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.32x
ROE-58.30%
Beta1.82
50D MA$1.42
200D MA$2.51
Shares out0.07B
Float0.06B
Short ratio
Avg volume0.8M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years